Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%)
< Home < Back

Cadila Healthcare reports 7% fall in consolidated Q2 net profit

Date: 07-11-2012

Cadila Healthcare has reported results for second quarter ended September 30, 2012.

The company has reported 57.81% fall in its net profit at Rs 97.45 crore for the quarter ended September 30, 2012 as compared to Rs 230.98 crore for the same quarter in the previous year. However, total income of the company has increased by 3.16% at Rs 794.84 crore for quarter under review as compared to Rs 770.51 crore for the quarter ended September 30, 2011.

On consolidated basis, the company has posted 7.34% fall in its net profit at Rs 95.14 crore for the quarter ended September 30, 2012 as compared to Rs 102.68 crore for the same quarter in the previous year. However, group’s total income has increased by 25.17% at Rs 1547.64 crore for quarter under review as compared to Rs 1236.40 crore for the quarter ended September 30, 2011.